(Q45887307)

17 December 2017

title

Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis (English)

1 reference

17 December 2017

1 reference

X Yao

1

1 reference

17 December 2017

Y Yoshioka

2

1 reference

17 December 2017

T Morishige

3

1 reference

17 December 2017

Y Eto

4

1 reference

17 December 2017

H Watanabe

5

1 reference

17 December 2017

Y Okada

6

1 reference

17 December 2017

H Mizuguchi

7

1 reference

17 December 2017

Y Mukai

8

1 reference

17 December 2017

N Okada

9

1 reference

17 December 2017

S Nakagawa

10

1 reference

17 December 2017

publication date

1 December 2009

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

16

1 reference

17 December 2017

issue

12

1 reference

17 December 2017

page(s)

1395-1404

1 reference

17 December 2017

Targeted adenovirus vectors

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Development of PEGylated adenovirus vector with targeting ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Current status of gene therapy in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Fiber-modified adenovirus vectors decrease liver toxicity through reduced IL-6 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Advances in PEGylation of important biotech molecules: delivery aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Exploiting the enhanced permeability and retention effect for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

21 January 2018

The p53 homology trap.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

TERT promoter-driven adenovirus vector for cancer gene therapy via systemic injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Innate immune response induced by gene delivery vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

The use of PVP as a polymeric carrier to improve the plasma half-life of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: results of a phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Advanced generation adenoviral virotherapy agents embody enhanced potency based upon CAR-independent tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Expression of coxsackie and adenovirus receptor reduces the lung metastatic potential of murine tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Efficient gene transfer by fiber-mutant adenoviral vectors containing RGD peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Virus treatment questioned after gene therapy death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Gene therapy death prompts review of adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Adenoviral expression of suppressor of cytokine signaling-1 reduces adenovirus vector-induced innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

"Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Elimination of innate immune responses and liver inflammation by PEGylation of adenoviral vectors and methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Resistance to 5-fluorouracil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

Recent progress on tumor missile therapy and tumor vascular targeting therapy as a new approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

inferred from DOI database lookup

7 January 2021

based on heuristic

Use of suicide genes in gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

inferred from DOI database lookup

7 January 2021

based on heuristic

A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.95

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2009.95

1 reference

17 December 2017

Dimensions Publication ID

1042671320

0 references

1 reference

17 December 2017